Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286466279> ?p ?o ?g. }
- W4286466279 endingPage "145" @default.
- W4286466279 startingPage "145" @default.
- W4286466279 abstract "Background: Type 2 diabetes mellitus (T2DM) is a progressive disease affecting a huge chunk of the population globally. Aim: This study aimed to address the existing gaps in knowledge about the triple-drug combination and to provide guidance to the clinicians on the triple-drug combination in Indian settings. Materials and Methods: Doctors’ opinions (n = 2262) were recorded based on surveys and round table meetings. The National Expert Group approved a standard questionnaire that included 13 questions pertaining to T2DM management using a triple combination of glimepiride, metformin, and voglibose, which were prepared, discussed, and evaluated by the experts. After due discussions, the expert group analyzed the result and further recommendations were made and a consensus statement was derived. Results: Out of 2262, 1498 were consulting physicians, 358 were diabetologists, 93 were endocrinologists, 104 were cardiologists, and 209 were family physicians with focus on diabetes practice or had more than 10 years of experience from different regions from India. A strong consensus was observed for targeting postprandial hyperglycemia in the management of T2DM, which may reduce cardiovascular (CV) disease risk. The experts opined that meal pattern was the major factor affecting glycemic variability. The experts recommended early use of triple combination as it improves glycemic control (early aggressive control, beyond three oral drugs are on no benefit, ingrained). More than 90.0% of clinicians believed that this combination is cost-effective. Most agreed (32.0%) that this combination moderately reduces body weight. Additionally, it was felt that triple combination in patients with T2DM is also beneficial during Ramadan. Conclusion: In the present expert opinion-based consensus, most of the healthcare providers believed that triple-drug combination can potentially improve glycemic control and can delay/postpone the microvascular and CV complications. However, more multicentric studies are needed to support these recommendations." @default.
- W4286466279 created "2022-07-22" @default.
- W4286466279 creator A5023292633 @default.
- W4286466279 creator A5031723792 @default.
- W4286466279 creator A5037280515 @default.
- W4286466279 creator A5040412228 @default.
- W4286466279 creator A5041593644 @default.
- W4286466279 creator A5044724678 @default.
- W4286466279 creator A5049789523 @default.
- W4286466279 creator A5049876759 @default.
- W4286466279 creator A5083344027 @default.
- W4286466279 creator A5083672286 @default.
- W4286466279 date "2022-01-01" @default.
- W4286466279 modified "2023-10-14" @default.
- W4286466279 title "Expert consensus on triple combination of glimepiride, metformin, and voglibose usage in patients with type 2 diabetes mellitus in Indian settings" @default.
- W4286466279 cites W1510299662 @default.
- W4286466279 cites W1585051518 @default.
- W4286466279 cites W1934660672 @default.
- W4286466279 cites W1967633321 @default.
- W4286466279 cites W1980453186 @default.
- W4286466279 cites W1983269691 @default.
- W4286466279 cites W1986364721 @default.
- W4286466279 cites W2005353723 @default.
- W4286466279 cites W2008877833 @default.
- W4286466279 cites W2022570922 @default.
- W4286466279 cites W2031245034 @default.
- W4286466279 cites W2032777249 @default.
- W4286466279 cites W2036555858 @default.
- W4286466279 cites W2048260881 @default.
- W4286466279 cites W2050039414 @default.
- W4286466279 cites W2050350823 @default.
- W4286466279 cites W2054381014 @default.
- W4286466279 cites W2072480954 @default.
- W4286466279 cites W2073068020 @default.
- W4286466279 cites W2099468119 @default.
- W4286466279 cites W2102671194 @default.
- W4286466279 cites W2108361694 @default.
- W4286466279 cites W2112182833 @default.
- W4286466279 cites W2113322194 @default.
- W4286466279 cites W2113506865 @default.
- W4286466279 cites W2125028944 @default.
- W4286466279 cites W2133980496 @default.
- W4286466279 cites W2147521434 @default.
- W4286466279 cites W2156600593 @default.
- W4286466279 cites W2159933679 @default.
- W4286466279 cites W2162419273 @default.
- W4286466279 cites W2168309836 @default.
- W4286466279 cites W2171294019 @default.
- W4286466279 cites W2290571019 @default.
- W4286466279 cites W2293438952 @default.
- W4286466279 cites W2337343211 @default.
- W4286466279 cites W2366221926 @default.
- W4286466279 cites W2460806720 @default.
- W4286466279 cites W2507901651 @default.
- W4286466279 cites W2596666371 @default.
- W4286466279 cites W2601439059 @default.
- W4286466279 cites W2753932519 @default.
- W4286466279 cites W2768276443 @default.
- W4286466279 cites W2798130906 @default.
- W4286466279 cites W2885657542 @default.
- W4286466279 cites W2886713969 @default.
- W4286466279 cites W2911704610 @default.
- W4286466279 cites W2932840059 @default.
- W4286466279 cites W2956735754 @default.
- W4286466279 cites W2957442078 @default.
- W4286466279 cites W2964576357 @default.
- W4286466279 cites W3038891123 @default.
- W4286466279 doi "https://doi.org/10.4103/jod.jod_118_21" @default.
- W4286466279 hasPublicationYear "2022" @default.
- W4286466279 type Work @default.
- W4286466279 citedByCount "0" @default.
- W4286466279 crossrefType "journal-article" @default.
- W4286466279 hasAuthorship W4286466279A5023292633 @default.
- W4286466279 hasAuthorship W4286466279A5031723792 @default.
- W4286466279 hasAuthorship W4286466279A5037280515 @default.
- W4286466279 hasAuthorship W4286466279A5040412228 @default.
- W4286466279 hasAuthorship W4286466279A5041593644 @default.
- W4286466279 hasAuthorship W4286466279A5044724678 @default.
- W4286466279 hasAuthorship W4286466279A5049789523 @default.
- W4286466279 hasAuthorship W4286466279A5049876759 @default.
- W4286466279 hasAuthorship W4286466279A5083344027 @default.
- W4286466279 hasAuthorship W4286466279A5083672286 @default.
- W4286466279 hasBestOaLocation W42864662791 @default.
- W4286466279 hasConcept C134018914 @default.
- W4286466279 hasConcept C177713679 @default.
- W4286466279 hasConcept C2776307423 @default.
- W4286466279 hasConcept C2776617576 @default.
- W4286466279 hasConcept C2777180221 @default.
- W4286466279 hasConcept C2778199505 @default.
- W4286466279 hasConcept C2780323712 @default.
- W4286466279 hasConcept C2780473172 @default.
- W4286466279 hasConcept C2908647359 @default.
- W4286466279 hasConcept C2910068830 @default.
- W4286466279 hasConcept C512399662 @default.
- W4286466279 hasConcept C555293320 @default.
- W4286466279 hasConcept C71924100 @default.
- W4286466279 hasConcept C99454951 @default.
- W4286466279 hasConceptScore W4286466279C134018914 @default.